Abstract
Pujan Shrestha, Jason Thomas George
Abstract
Authors
Institutions
No local reference links have been materialized yet.
No local citing links have been materialized yet.
10.1146/annurev.immunol.22.012703.104803
10.1146/annurev.immunol.22.012703.104803
Stochastic modeling of tumor progression and immune evasion
10.1016/j.jtbi.2018.09.012 · 2018
10.1007/s11538-026-01665-9
10.1007/s11538-026-01665-9
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013
10.1158/2159-8290.cd-21-1059
10.1158/2159-8290.cd-21-1059
10.2307/j.ctvjghw98
10.2307/j.ctvjghw98
10.1371/journal.pbio.0060299
10.1371/journal.pbio.0060299
The apoptosis paradox in cancer
10.3390/ijms23031328 · 2022
10.1038/s41580-018-0089-8
10.1038/s41580-018-0089-8
10.1038/nrm3722
10.1038/nrm3722
10.1016/0025-5564(90)90021-p
10.1016/0025-5564(90)90021-p
Bang-bang optimal controls for a mathematical model of chemo-and immunotherapy in cancer
Provenance
crossref
Confidence 100%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
ror
Confidence 99%
pubmed
Confidence 98%
openalex
Confidence 95%
datacite
Confidence 0%
10.3934/dcdsb.2023141 · 2024
Computational approaches to modelling and optimizing cancer treatment
10.1038/s44222-023-00089-7 · 2023
Optimal control theory and calculus of variations in mathematical models of chemotherapy of malignant tumors
10.3390/math11204301 · 2023
10.1016/j.cma.2022.115484
10.1016/j.cma.2022.115484
Cancer treatment precision strategies through optimal control theory
2024
10.1007/978-1-4939-2972-6
10.1007/978-1-4939-2972-6
Optimal control theory for personalized therapeutic regimens in oncology: Background, history, challenges, and opportunities
10.3390/jcm9051314 · 2020
An optimal control framework for the automated design of personalized cancer treatments
10.3389/fbioe.2020.00523 · 2020
Optimal control for cancer treatment mathematical model using atangana–baleanu–caputo fractional derivative
10.1186/s13662-020-02793-9 · 2020
Control theory and cancer chemotherapy: how they interact
10.3389/fbioe.2020.621269 · 2021
Optimal adaptive cancer therapy based on evolutionary game theory
10.1371/journal.pone.0320677 · 2025
10.2139/ssrn.5931214
10.2139/ssrn.5931214
Optimal treatment strategy for cancer based on mathematical modeling and impulse control theory
10.3390/axioms12100916 · 2023
Does cancer solve an optimization problem?
10.4161/cc.3.7.974 · 2004
Genetic instability in cancer: an optimal control problem
2010
10.1073/pnas.0401943101
10.1073/pnas.0401943101
An evolutionary model of carcinogenesis
2003
Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles
10.7554/elife.82786 · 2023
Integrating inverse reinforcement learning into data-driven mechanistic computational models: a novel paradigm to decode cancer cell heterogeneity
10.3389/fsysb.2024.1333760 · 2024
Unresolved referenced work
Kept as external metadata until matched
How modulation of the tumor microenvironment drives cancer immune escape dynamics
10.1038/s41598-025-91396-z · 2025
10.1158/0008-5472.can-19-2732
10.1158/0008-5472.can-19-2732
10.1016/j.canlet.2016.05.012
10.1016/j.canlet.2016.05.012
Bone marrow microenvironment-induced regulation of bcl-2 family members in multiple myeloma (mm): therapeutic implications
10.1016/j.cyto.2022.156062 · 2023
Cafs mediate carboplatin resistance in luad via cxcl12 secretion regulated by nf-κb activation
10.1007/s13402-025-01106-0 · 2025
Matrix stiffness enhances viability, migration, invasion and invadopodia formation of oral cancer cells via pi3k/akt pathway in vitro
10.1186/s40001-025-02666-5 · 2025
Distinct evolutionary patterns of tumour-immune escape and elimination determined by extracellular matrix architectures
10.1098/rsif.2025.0116 · 2025
10.1098/rsos.150016
10.1098/rsos.150016
Biological time value
10.1016/0025-5564(90)90050-9 · 1990
10.1073/pnas.1812810116
10.1073/pnas.1812810116 · doi-reference
10.1016/j.cell.2016.03.025
10.1016/j.cell.2016.03.025 · doi-reference
10.3390/cells13110924
10.3390/cells13110924 · doi-reference
10.1186/1756-9966-30-87
10.1186/1756-9966-30-87 · doi-reference
Evolutionary origins of temporal discounting: modeling how time and uncertainty constrain optimal decision-making strategies across taxa
10.1371/journal.pone.0310658 · doi-reference
Biological time value
10.1016/0025-5564(90)90050-9 · doi-reference
10.1098/rsos.150016
10.1098/rsos.150016 · doi-reference
Distinct evolutionary patterns of tumour-immune escape and elimination determined by extracellular matrix architectures
10.1098/rsif.2025.0116 · doi-reference
Matrix stiffness enhances viability, migration, invasion and invadopodia formation of oral cancer cells via pi3k/akt pathway in vitro
10.1186/s40001-025-02666-5 · doi-reference
Cafs mediate carboplatin resistance in luad via cxcl12 secretion regulated by nf-κb activation
10.1007/s13402-025-01106-0 · doi-reference
Bone marrow microenvironment-induced regulation of bcl-2 family members in multiple myeloma (mm): therapeutic implications
10.1016/j.cyto.2022.156062 · doi-reference
10.1016/j.canlet.2016.05.012
10.1016/j.canlet.2016.05.012 · doi-reference
10.1158/0008-5472.can-19-2732
10.1158/0008-5472.can-19-2732 · doi-reference
How modulation of the tumor microenvironment drives cancer immune escape dynamics
10.1038/s41598-025-91396-z · doi-reference
Integrating inverse reinforcement learning into data-driven mechanistic computational models: a novel paradigm to decode cancer cell heterogeneity
10.3389/fsysb.2024.1333760 · doi-reference
Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles
10.7554/elife.82786 · doi-reference
Does cancer solve an optimization problem?
10.4161/cc.3.7.974 · doi-reference
Optimal treatment strategy for cancer based on mathematical modeling and impulse control theory
10.3390/axioms12100916 · doi-reference
10.2139/ssrn.5931214
10.2139/ssrn.5931214 · doi-reference
Optimal adaptive cancer therapy based on evolutionary game theory
10.1371/journal.pone.0320677 · doi-reference
Control theory and cancer chemotherapy: how they interact
10.3389/fbioe.2020.621269 · doi-reference
Optimal control for cancer treatment mathematical model using atangana–baleanu–caputo fractional derivative
10.1186/s13662-020-02793-9 · doi-reference
An optimal control framework for the automated design of personalized cancer treatments
10.3389/fbioe.2020.00523 · doi-reference
Optimal control theory for personalized therapeutic regimens in oncology: Background, history, challenges, and opportunities
10.3390/jcm9051314 · doi-reference
10.1007/978-1-4939-2972-6
10.1007/978-1-4939-2972-6 · doi-reference
10.1016/j.cma.2022.115484
10.1016/j.cma.2022.115484 · doi-reference
Optimal control theory and calculus of variations in mathematical models of chemotherapy of malignant tumors
10.3390/math11204301 · doi-reference
Computational approaches to modelling and optimizing cancer treatment
10.1038/s44222-023-00089-7 · doi-reference
Bang-bang optimal controls for a mathematical model of chemo-and immunotherapy in cancer
10.3934/dcdsb.2023141 · doi-reference
10.1016/0025-5564(90)90021-p
10.1016/0025-5564(90)90021-p · doi-reference
10.1038/nrm3722
10.1038/nrm3722 · doi-reference
10.1038/s41580-018-0089-8
10.1038/s41580-018-0089-8 · doi-reference
The apoptosis paradox in cancer
10.3390/ijms23031328 · doi-reference
10.1073/pnas.0401943101
10.1073/pnas.0401943101 · doi-reference
10.1371/journal.pbio.0060299
10.1371/journal.pbio.0060299 · doi-reference
10.2307/j.ctvjghw98
10.2307/j.ctvjghw98 · doi-reference
10.1158/2159-8290.cd-21-1059
10.1158/2159-8290.cd-21-1059 · doi-reference
10.1016/j.cell.2011.02.013
10.1016/j.cell.2011.02.013 · doi-reference
10.1007/s11538-026-01665-9
10.1007/s11538-026-01665-9 · doi-reference
Stochastic modeling of tumor progression and immune evasion
10.1016/j.jtbi.2018.09.012 · doi-reference